Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Receives $26.04 Consensus Target Price from Analysts

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) have been given an average recommendation of “Hold” by the sixteen ratings firms that are presently covering the company, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. The average 1 year price objective among analysts that have updated their coverage on the stock in the last year is $26.0385.

Several equities analysts have recently weighed in on the company. Zacks Research upgraded Acadia Healthcare from a “strong sell” rating to a “hold” rating in a report on Thursday, March 5th. Weiss Ratings reiterated a “sell (d)” rating on shares of Acadia Healthcare in a report on Wednesday, January 21st. Royal Bank Of Canada lifted their price objective on Acadia Healthcare from $28.00 to $31.00 and gave the company an “outperform” rating in a report on Monday, May 4th. UBS Group lifted their price objective on Acadia Healthcare from $27.00 to $31.00 and gave the company a “buy” rating in a report on Friday, April 17th. Finally, Guggenheim boosted their target price on Acadia Healthcare from $26.00 to $31.00 and gave the company a “buy” rating in a research note on Monday, May 4th.

Institutional Investors Weigh In On Acadia Healthcare

Institutional investors have recently bought and sold shares of the company. EverSource Wealth Advisors LLC raised its stake in shares of Acadia Healthcare by 54.8% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after purchasing an additional 497 shares in the last quarter. Wells Fargo & Company MN increased its holdings in shares of Acadia Healthcare by 208.9% during the 4th quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock worth $32,000 after acquiring an additional 1,510 shares during the last quarter. Bayforest Capital Ltd acquired a new position in shares of Acadia Healthcare during the 4th quarter worth approximately $52,000. Hantz Financial Services Inc. grew its holdings in Acadia Healthcare by 501.9% in the 3rd quarter. Hantz Financial Services Inc. now owns 2,185 shares of the company’s stock valued at $54,000 after buying an additional 1,822 shares in the last quarter. Finally, GAMMA Investing LLC grew its holdings in Acadia Healthcare by 124.7% in the 4th quarter. GAMMA Investing LLC now owns 4,862 shares of the company’s stock valued at $69,000 after buying an additional 2,698 shares in the last quarter.

Acadia Healthcare Price Performance

Acadia Healthcare stock opened at $27.15 on Monday. The firm has a market capitalization of $2.50 billion, a P/E ratio of -2.22, a PEG ratio of 8.73 and a beta of 0.73. Acadia Healthcare has a 1 year low of $11.43 and a 1 year high of $30.20. The business has a 50-day moving average of $25.17 and a 200-day moving average of $19.19. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 1.27.

Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Wednesday, April 29th. The company reported $0.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.28 by $0.09. Acadia Healthcare had a positive return on equity of 7.09% and a negative net margin of 32.84%.The company had revenue of $828.80 million during the quarter, compared to analyst estimates of $823.51 million. During the same period in the previous year, the company earned $0.40 EPS. The company’s revenue for the quarter was up 7.6% compared to the same quarter last year. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. On average, equities analysts anticipate that Acadia Healthcare will post 1.49 EPS for the current year.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.